SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,111,281. The last known price of Bitcoin is 71,086.72423286 USD and is down -3.89 over the last 24 hours. It is currently trading on 12779 active market(s) with $28,515,435,687.36 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins steep selloff is driving attention, with traders pointing to leveraged long liquidations and broader risk-off pressure. The community is split between buying an oversold dip near technical support and expecting further declines if selling continues.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Phase 3 REGAL trial of GPS has reached the 80th event, and the company expects topline results this month, driving intense attention ahead of the AML data readout. Traders celebrated a sharp after-hours move and speculated about a data leak or short covering, while others cautioned that the trial remains blinded and its outcome is unknown.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSCIs decision to remove Strategy from its indexes is fueling concerns about passive fund selling, while Bitcoins decline adds pressure to the stock. Traders debate whether the potential outflows are already priced in and whether the exclusion will materially weaken Strategys Bitcoin-linked financing model.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

A widespread Microsoft 365 outage disrupted Outlook, Teams, Copilot and other services, prompting complaints from users whose work was interrupted. Traders debated whether the prolonged disruption should pressure the stock, which held near flat-to-positive, while some speculated about a cyberattack without confirmation.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.03439229 USD and is down -2.16 over the last 24 hours. It is currently trading on 1895 active market(s) with $1,786,076,895.36 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRP is sliding alongside a broader crypto selloff, with traders pointing to risk-off sentiment, inflation and rate-hike concerns, and leveraged liquidations. The steep decline has sparked debate over whether support will hold or losses will deepen, while some holders are buying the dip and others cite stalled regulatory progress and weak demand as reasons for caution.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs resignation and Colette Kresss interim appointment have rattled NVDA shares, with traders also debating potential China chip-export scrutiny and the companys reliance on Huangs leadership. The community is split between buying the selloff on confidence in Nvidias AI business and avoiding the stock amid leadership and regulatory uncertainty.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,962,604.07029401. The last known price of Zcash is 956.58767703 USD and is down -2.92 over the last 24 hours. It is currently trading on 670 active market(s) with $828,877,374.43 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcashs sharp pullback after a major rally is dominating discussion, with traders debating whether it is a broader crypto-market correction and liquidation flush or a deeper breakdown. Some call the selloff an oversold buying opportunity, while bears point to lost support and continued selling.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels planned prostate-cancer BLA filing has been pushed to mid-2027 amid FDA discussions and assay refinement, prompting a sharp selloff and criticism of managements communication and credibility. Some traders see the delay as a manufacturing and regulatory hurdle rather than a problem with the clinical data, while others remain concerned about execution and the longer wait.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is under pressure alongside Bitcoins slide and broader weakness in crypto-linked stocks, with traders highlighting fresh lows and arguing over whether the selloff has further to run or the shares are forming a base. Some also point to COINs underperformance versus Bitcoin and concerns about trading activity, while a smaller group sees an oversold bounce opportunity.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BMNR is drawing attention amid weakness in Ethereum and broader crypto-linked stocks, with traders focused on its ETH-treasury exposure and the shares decline. The community is split between dip-buyers expecting a recovery and critics questioning Tom Lees strategy, company spending, transparency and buybacks.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Brief India: Powerica IPO: Powering Ahead to Attain A Long Term Growth Trajectory and more

In this briefing: Powerica IPO: Powering Ahead to Attain A Long Term Growth Trajectory Pan-Asia Alpha Signals: Korea & Taiwan Dominate, India Underperformance Deepens India Top Longs APAC Healthcare Weekly (March 22) – Hengrui, Microport Neuro, Celltrion, Samsung Bio, Sun Pharma The GLP-1 Super-Cycle: Deconstructing India’s 2026 Patent Cliff and Alpha Generators 1. Powerica IPO: Powering Ahead to Attain A Long Term Growth Trajectory Powerica has launched IPO to raise up to INR 11B. The company plans to sell 27.8M shares at between INR 375 - 395 per share. Powerica is an integrated power solutions provider specializing in diesel generator sets, for both primary and standby applications. It also operates in wind power sector as an independent power producer. Investors can subscribe to the issue considering the stable business model, strong brand association, expertise in power segment and strategic advantage in attaining long term sustained growth trajectory. 2. Pan-Asia Alpha Signals: Korea & Taiwan Dominate, India Underperformance Deepens Decay Analysis : Compared Long IR vs.

Brief India: Pan-Asia Alpha Signals: Korea & Taiwan Dominate, India Underperformance Deepens and more

In this briefing: Pan-Asia Alpha Signals: Korea & Taiwan Dominate, India Underperformance Deepens India Top Longs APAC Healthcare Weekly (March 22) – Hengrui, Microport Neuro, Celltrion, Samsung Bio, Sun Pharma The GLP-1 Super-Cycle: Deconstructing India’s 2026 Patent Cliff and Alpha Generators Primer: CESC Ltd (CESC IN) - Mar 2026 1. Pan-Asia Alpha Signals: Korea & Taiwan Dominate, India Underperformance Deepens Decay Analysis : Compared Long IR vs. Short IR to spot momentum acceleration (Taiwan +1.9, Korea +0.9) versus alpha erosion (India -1.5, Comm Svcs -1.2). Leaders/Laggards Analysis : Short IR values identified performance leaders (Korea at 3.0, Taiwan at 2.7) and laggards (India at -3.1, Comm Svcs at -1.9). India/China A/Real Estate remain chronic underperformers. Tactical Tilts : favor high-momentum, tech-heavy markets, avoid deteriorating sectors / regions. 2. India Top Longs Structural tailwinds across electrification, transmission, data centers, and specialty pharma remain intact, but these are now consensus trades with expectations fully embedded in earnings and multiples.

Brief India: India Top Longs and more

In this briefing: India Top Longs APAC Healthcare Weekly (March 22) – Hengrui, Microport Neuro, Celltrion, Samsung Bio, Sun Pharma The GLP-1 Super-Cycle: Deconstructing India’s 2026 Patent Cliff and Alpha Generators Primer: CESC Ltd (CESC IN) - Mar 2026 Aequitas: Truhome Finance Limited Pre-IPO Tearsheet 1. India Top Longs Structural tailwinds across electrification, transmission, data centers, and specialty pharma remain intact, but these are now consensus trades with expectations fully embedded in earnings and multiples. Our long basket—ABB India, Hitachi Energy India, Cummins India, and Sun Pharma—represents high-quality proxies where delivery, not discovery, will drive relative outperformance If markets turn, these businesses remain best positioned given strong balance sheets, visible demand, and execution track record—making them relative winners even in a tougher environment. 2. APAC Healthcare Weekly (March 22) – Hengrui, Microport Neuro, Celltrion, Samsung Bio, Sun Pharma Hengrui Pharma received indication expansion approval for trastuzumab rezetecan in China.

Brief Multi-Strategy: Overview #54 – The Spice Must Flow and more

In this briefing: Overview #54 – The Spice Must Flow APAC Healthcare Weekly (March 22) – Hengrui, Microport Neuro, Celltrion, Samsung Bio, Sun Pharma Hong Kong Single Stock Options Weekly (Mar 16–20): Call Volumes Elevated Ahead Of Busy Earnings Week KT&G: Share Cancellation of 1.7 Trillion Won and a Potential Hike in Cigarette Prices in 2026 The GLP-1 Super-Cycle: Deconstructing India’s 2026 Patent Cliff and Alpha Generators 1. Overview #54 – The Spice Must Flow A review of recent events/data impacting our investment themes and outlook The oil shock is now morphing into a liquidity shock Market action is starting to signal an upcoming US recession 2. APAC Healthcare Weekly (March 22) – Hengrui, Microport Neuro, Celltrion, Samsung Bio, Sun Pharma Hengrui Pharma received indication expansion approval for trastuzumab rezetecan in China. MicroPort NeuroScientific’s Apollo Dream Rapamycin Target Eluting Stent has been granted the Breakthrough Device Designation by the FDA. Celltrion signed KRW375B CMO agreement with a global pharmaceutical company for the supply of drug substance.

Brief India: APAC Healthcare Weekly (March 22) – Hengrui, Microport Neuro, Celltrion, Samsung Bio, Sun Pharma and more

In this briefing: APAC Healthcare Weekly (March 22) – Hengrui, Microport Neuro, Celltrion, Samsung Bio, Sun Pharma The GLP-1 Super-Cycle: Deconstructing India’s 2026 Patent Cliff and Alpha Generators Primer: CESC Ltd (CESC IN) - Mar 2026 Aequitas: Truhome Finance Limited Pre-IPO Tearsheet Aequitas: CMPDI Ltd IPO - Asset-Light Mining Consultancy with Strong Parentage, Priced In Line 1. APAC Healthcare Weekly (March 22) – Hengrui, Microport Neuro, Celltrion, Samsung Bio, Sun Pharma Hengrui Pharma received indication expansion approval for trastuzumab rezetecan in China. MicroPort NeuroScientific’s Apollo Dream Rapamycin Target Eluting Stent has been granted the Breakthrough Device Designation by the FDA. Celltrion signed KRW375B CMO agreement with a global pharmaceutical company for the supply of drug substance. Samsung Bioepis entered global commercialization agreement with Sandoz for five biosimilar candidates under development. FDA accepted Sun Pharma’s indication expansion application for Ilumya for active psoriatic arthritis.

Indian Markets Extend Gains For Second Week; Nifty Ends Near 25,300, Sensex Surges Over 1,000 Points

Equity

Optimism over an India–US trade deal and easing geopolitical tensions boosted investor sentiment. Buying in real estate, pharma, and PSU banks offset weakness in metals and tech stocks.


US Biosecure Act Boosts Indian Pharma: CDMO Stocks Gained Upto 5%

The legislation seeks to protect American biotech and health data from potential foreign threats, especially from Chinese firms

Indian Markets Open Weak After Six-Day Rally, Nifty Slips Below 25,000; Financials, Metals Drag

Analysts suggest a buy-on-dips strategy for the Nifty. Investors now await US Fed Chair Jerome Powell’s Jackson Hole speech for global cues.


Tariff Jitters, RBI’s Pause Drag Nifty Below 24,600; Pharma, Tech Stocks Sink, NSDL Soars 17% On Debut

Trump’s tariff threats spooked investors. Analysts flagged early warning signals in tech and pharma sectors.


Divi’s Labs Shares Dip After Patent Loss: SEBI RA Recommends Buy On Dips

The stock slid to an intraday low of ₹6,545 on Monday following a gap-down open, as investors reacted to MSN’s legal win over Entresto. 

Divi's Laboratories Ltd. is a holding company, which engages in the manufacture of active pharmaceutical ingredients, intermediates, and nutraceuticals. It also provides manufacturing of generic APIs, nutraceutical ingredients, and custom synthesis for big pharma. It operates through the following segments: Generic API, Custom Synthesis, and Nutraceuticals. The company was founded by Murali Krishna Prasad Divi on October 12, 1990 and is headquartered in Hyderabad, India.

Divi`s Laboratories Ltd.

Bearish Sentiment

Indian equity markets ended higher, with the Nifty index closing below 25,300, led by buying in real estate, pharma, and PSU banks. Metals and technology were the only indices to end in the red on Friday. Renewed optimism over a potential India–US trade deal before the November deadline, along with easing geopolitical tensions in the Middle East, aided investor sentiment.Benchmarks ended higher for the second straight week, gaining over 1.5% and seeing their biggest weekly gains in three months.&nbsp;On Friday, the Sensex closed 1098 points higher at 82,500, while the&nbsp;<a href="https://stocktwits.com/symbol/NIFTY50.NSE">Nifty 50</a> ended up 103 points at 25,285. Broader markets mirrored the gains, with the Nifty Midcap index rising 0.4% and the Smallcap index gaining 0.6%.The retail investor sentiment surrounding the Nifty 50 remained ‘bullish’ by market close on Stocktwits.<figure class="image"><img style="aspect-ratio:804/97;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_10_154349_png_b11c534be4.webp" alt="Screenshot 2025-10-10 154349.png" width="804" height="97"><figcaption>Nifty sentiment and message volume on Oct 10 as of 4:10 pm IST. | source: Stocktwits</figcaption></figure>Stock MovesTCS was among the top Nifty losers, shedding 1% despite steady performance in the September quarter (Q2) earnings. Tata Communications surged 10% on a sentiment boost as TCS unveiled ambitious AI plans that included setting up a 1 GW data centre in India.&nbsp;Weak Q2 performance dragged Tata Elxsi 3% lower.&nbsp;Pharma stocks such as&nbsp;Divi’s Labs, Piramal Pharma, and Wockhardt gained between 3% and 5% after the US Senate passed the National Defense Authorisation Act (NDAA), which includes an amended version of the Biosecure Act.&nbsp; The legislation seeks to protect American biotech and health data from potential foreign threats, especially from Chinese firms.&nbsp;Textile stocks such as Gokaldas, Indo Count surged over 5% on&nbsp;news reports that India-UK are likely to double trade by 2030Man Industries surged 4% after the Securities Appellate Tribunal (SAT) granted a stay on SEBI’s order against the company, which directed it to deposit 50% of the imposed penalty.And new entrant, WeWork India, ended over 2% lower after a muted listing on the bourses.Stock Calls<a href="https://stocktwits.com/Ca_mayankchandel">Mayank Singh Chandel</a> recommended buying&nbsp;<a href="https://stocktwits.com/symbol/LTFOODS.NSE">LT Foods</a>. The stock has found support at a rising trendline and is currently trading just below its 200-day Exponential Moving Average (EMA). In the past, the stock has bounced back from the 200 EMA or slightly below it, demonstrating strong support at this level, which makes the current price a good entry point.&nbsp;He suggested entering at the current market price with a stop loss below ₹375. Short-term price target is set at ₹420, with a medium-term target at ₹500.<stembedurl>https://stocktwits.com/Ca_mayankchandel/message/631777420</stembedurl><a href="https://stocktwits.com/investkaps">Kapil Aggarwal of InvestKaps</a> recommended buying AMAL at the current price of ₹950-₹1,000 for a target of ₹1,200 and a stop loss of ₹900. The stock has seen a healthy, well-channeled correction and taken support around its 20-week EMA. It looks poised for an upmove to a new high.<stembedurl>https://stocktwits.com/investkaps/message/631778299</stembedurl>Markets: What Next?Globally, European markets traded mixed, while US stock futures indicate a subdued start on Wall Street as the US government shutdown is likely to extend into next week.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

(Photo by Indranil Aditya/NurPhoto via Getty Images)

Optimism over an India–US trade deal and easing geopolitical tensions boosted investor sentiment. Buying in real estate, pharma, and PSU banks offset weakness in metals and tech stocks.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	32.52	--	--	N/A
Q2 '26	32.10	42.49	32.38%	BEAT
Q1 '26	24.68	33.95	37.58%	BEAT
Q4 '25	26.43	28.31	7.10%	BEAT
Q3 '25	23.00	21.98	-4.45%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

DIVISLAB.NSE Earnings

Latest Earnings Results: Q2 '26

Historical Earnings